Company intelligence / Profile preview

F1000Research

London, United Kingdom
Ownership
Private
Development stage
Other
01

Overview

F1000Research is a multidisciplinary open access publishing platform launched in 2013, offering rapid publication with post-publication open peer review. It publishes research articles, software tools, data notes, clinical trials, and other outputs across life sciences, medicine, physical sciences, social sciences, and humanities. Owned by Taylor & Francis since January 2020. Part of F1000, originally Faculty of 1000 founded in 2000.

Industry
Biomedical IT and Biomedical Data Platforms
02

Partnerships

Taylor & FrancisBill & Melinda Gates FoundationEuropean CommissionWellcome

Beyond the preview

Go deeper on F1000Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F1000Research.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call